Importantly, neuroblastoma highly relies on fatty acid oxidation for energy production, and inhibition of β-oxidation leads to reduced growth of MYCN-amplified, but not of non-MYCN-amplified, cells and tumors (Oliynyk et al., 2019). The gene discussed is MYCN; the disease is neuroblastoma.